INTRAVENOUS CYCLOPHOSPHAMIDE COMBINED THERAPY IN SEVERE LUPUS NEPHRITIS: IMMEDIATE AND LONG-TERM RESULTS

被引：0
|
作者：
Vachvanichsanong, P. [1 ]
Dissaneewate, P. [1 ]
McNeil, E. [2 ]
机构：
[1] Prince Songkla Univ, Hat Yai, Thailand
[2] Prince Songkla Univ, Epidemiol Unit, Hat Yai, Thailand
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [21] Long-Term Evaluation of Bone Mineral Density Change in Women Receiving Depot Leuprolide Acetate during Cyclophosphamide Therapy for Severe Lupus Nephritis
    Meier, Nathan
    Dooley, Mary Anne
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3327 - 3328
  • [22] INTRAVENOUS CYCLOPHOSPHAMIDE (CP) PULSE THERAPY FOR LUPUS NEPHRITIS - DURATION OF INDUCTION THERAPY
    SCHAUMANN, D
    HEIN, R
    WITTE, T
    SCHMIDT, RE
    BRUNKHORST, R
    NEUMANN, KH
    DEICHER, H
    KOCH, KM
    KIDNEY INTERNATIONAL, 1993, 44 (01) : 249 - 249
  • [23] Long-term outcome in lupus nephritis
    Spiera, RF
    Home, P
    Spiera, H
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (06) : 545 - 545
  • [24] SHORT AND LONG-TERM OUTCOME OF IV CYCLOPHOSPHAMIDE THERAPY IN PATIENTS WITH BILAG RENAL A SCORES DUE TO LUPUS NEPHRITIS
    Gordon, C.
    Heaton, S.
    Skan, J.
    Bacon, P.
    RHEUMATOLOGY, 2002, 41 : 106 - 107
  • [25] Efficacy of early vigorous therapy with intravenous Cyclophosphamide (IVCTX) on the long term renal outcome in patients with Active Lupus Nephritis (ALN).
    Maldonado, I
    Nouel, A
    Tilac, C
    Acosta, C
    Pernalete, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0441 - A0441
  • [26] Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome)
    Meral Calguneri
    Zeynep Ozbalkan
    M. Akif Ozturk
    Sule Apras
    A. Ihsan Ertenli
    Sedat Kiraz
    Clinical Rheumatology, 2006, 25 : 782 - 788
  • [27] Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome)
    Calguneri, Meral
    Ozbalkan, Zeynep
    Ozturk, M. Akif
    Apras, Sule
    Ertenli, A. Ihsan
    Kiraz, Sedat
    CLINICAL RHEUMATOLOGY, 2006, 25 (06) : 782 - 788
  • [28] THE ECONOMIC-IMPACT OF TREATMENT OF SEVERE LUPUS NEPHRITIS WITH PREDNISONE AND INTRAVENOUS CYCLOPHOSPHAMIDE
    MCINNES, PM
    SCHUTTINGA, J
    SANSLONE, WR
    STARK, SP
    KLIPPEL, JH
    ARTHRITIS AND RHEUMATISM, 1994, 37 (07): : 1000 - 1006
  • [29] Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil
    Prasad, Narayan
    Kurian, Jithu
    Agarwal, Vikas
    Bhadauria, Dharmendra
    Behera, Manas
    Yacha, Monika
    Kushwaha, Ravi
    Agrawal, Vinita
    Jain, Manoj
    Gupta, Amit
    LUPUS, 2020, 29 (08) : 845 - 853
  • [30] LONG-TERM (LT) FOLLOW-UP OF INTRAVENOUS PULSE CYCLOPHOSPHAMIDE (IPC) IN TYPE-IV LUPUS NEPHRITIS (LN)
    EISER, AR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 349 - 349
12345